CCP
ELV icon

Clarkston Capital Partners’s Elevance Health ELV Stock Holding History

Clarkston Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-47,379
Closed -$9M – 98
2017
Q3 		$9M Sell
47,379
-5,970
-11% -$1.14M 0.37% 44
2017
Q2 		$10M Sell
53,349
-590
-1% -$106K 0.45% 44
2017
Q1 		$8.92M Sell
53,939
-24,370
-31% -$3.88M 0.42% 47
2016
Q4 		$11.3M Sell
78,309
-960
-1% -$129K 0.54% 43
2016
Q3 		$9.93M Buy
79,269
+13,870
+21% +$1.79M 0.48% 47
2016
Q2 		$8.59M Buy
65,399
+1,825
+3% +$250K 0.45% 48
2016
Q1 		$8.84M Buy
63,574
+905
+1% +$121K 0.49% 47
2015
Q4 		$8.74M Buy
62,669
+1,520
+2% +$209K 0.61% 45
2015
Q3 		$8.56M Sell
61,149
-810
-1% -$122K 0.78% 46
2015
Q2 		$10.2M Sell
61,959
-465
-0.7% -$74.3K 1.05% 41
2015
Q1 		$9.64M Buy
62,424
+35,509
+132% +$5.06M 1.06% 40
2014
Q4 		$3.38M Sell
26,915
-2,105
-7% -$260K 0.51% 53
2014
Q3 		$3.47M Buy
29,020
+130
+0.4% +$14.9K 0.6% 51
2014
Q2 		$3.11M Sell
28,890
-3,134
-10% -$323K 0.57% 52
2014
Q1 		$3.19M Buy
32,024
+3,130
+11% +$283K 0.64% 48
2013
Q4 		$2.67M Sell
28,894
-7,589
-21% -$674K 1.04% 34
2013
Q3 		$3.05M Sell
36,483
-550
-1% -$47.1K 1.48% 23
2013
Q2 		$3.03M Buy
+37,033
New +$2.77M 1.68% 19

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Clarkston Capital Partners's ELV Position: Q4 2017 in Review

Clarkston Capital Partners sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 47,379 shares — an estimated $9M sold.

Clarkston Capital Partners first reported a position in ELV in Q2 2013 and held it in 18 quarters. The position peaked at $11.3M in Q4 2016. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • Clarkston Capital Partners reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
  • Clarkston Capital Partners sold 47,379 Elevance Health shares in Q4 2017, an estimated $9M.
  • Clarkston Capital Partners first reported a position in Elevance Health in Q2 2013 and held it in 18 quarters.
  • Clarkston Capital Partners's Elevance Health position peaked at $11.3M in Q4 2016.
  • 909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Clarkston Capital Partners's 13F filing for Q4 2017, filed 22 Jan 2018.